Department of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239-3098, USA.
Transgenic Mouse Models Shared Resource, Oregon Health & Science University, Portland, OR, 97239, USA.
Transl Stroke Res. 2023 Oct;14(5):766-775. doi: 10.1007/s12975-022-01093-6. Epub 2022 Oct 1.
No current treatments target microvascular reperfusion after stroke, which can contribute to poor outcomes even after successful clot retrieval. The G protein-coupled receptor GPR39 is expressed in brain peri-capillary pericytes, and has been implicated in microvascular regulation, but its role in stroke is unknown. We tested the hypothesis that GPR39 plays a protective role after stroke, in part due to preservation of microvascular perfusion. We generated GPR39 knockout (KO) mice and tested whether GPR39 gene deletion worsens capillary blood flow and exacerbates brain injury and functional deficit after focal cerebral ischemia. Stroke was induced in male and female GPR39 KO and WT littermates by 60-min middle cerebral artery occlusion (MCAO). Microvascular perfusion was assessed via capillary red blood cell (RBC) flux in deep cortical layers in vivo using optical microangiography (OMAG). Brain injury was assessed by measuring infarct size by 2,3,5-triphenyltetrazolium chloride staining at 24 h or brain atrophy at 3 weeks after ischemia. Pole and cylinder behavior tests were conducted to assess neurological function deficit at 1 and 3 weeks post-stroke. Male but not female GPR39 KO mice exhibited larger infarcts and lower capillary RBC flux than WT controls after stroke. Male GPR39 KO mice also exhibited worse neurologic deficit at 1 week post-stroke, though functional deficit disappeared in both groups by 3 weeks. GPR39 deletion worsens brain injury, microvascular perfusion, and neurological function after experimental stroke. Results indicate that GPR39 plays a sex-dependent role in re-establishing microvascular flow and limiting ischemic brain damage after stroke.
目前尚无针对中风后微血管再灌注的治疗方法,即使在成功清除血栓后,这也可能导致不良后果。G 蛋白偶联受体 GPR39 在脑周细胞的毛细血管周围表达,并且与微血管调节有关,但它在中风中的作用尚不清楚。我们检验了这样一个假设,即 GPR39 在中风后发挥保护作用,部分原因是微血管灌注得以维持。我们生成了 GPR39 敲除 (KO) 小鼠,并测试了 GPR39 基因缺失是否会恶化毛细血管血流,并加剧局灶性脑缺血后的脑损伤和功能缺陷。雄性和雌性 GPR39 KO 和 WT 同窝仔鼠通过 60 分钟大脑中动脉闭塞 (MCAO) 诱导中风。使用光学微血管造影 (OMAG) 在体内评估深层皮质层中的毛细血管红细胞 (RBC) 通量,以评估微血管灌注。通过 2,3,5-三苯基氯化四氮唑染色在 24 小时或缺血后 3 周评估脑梗死大小来评估脑损伤。在中风后 1 和 3 周进行棒和圆柱行为测试,以评估神经功能缺陷。与 WT 对照组相比,雄性而非雌性 GPR39 KO 小鼠在中风后表现出更大的梗死面积和更低的毛细血管 RBC 通量。雄性 GPR39 KO 小鼠在中风后 1 周还表现出更严重的神经功能缺陷,但两组在 3 周时功能缺陷均消失。GPR39 缺失会加重实验性中风后的脑损伤、微血管灌注和神经功能障碍。结果表明,GPR39 在中风后重新建立微血管血流和限制缺血性脑损伤方面发挥性别依赖性作用。